Novartis sales and marketing update

Genentech Inc. and Novartis co-market Xolair, a recombinant humanized mAb against IgE, in the U.S., and Novartis markets it elsewhere. Lucentis, a humanized mAb fragment against VEGF-A, is marketed ...